Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

Ibon Martínez‐Arranz, Chiara Bruzzone, Mazen Noureddin, Ruben Gil‐Redondo, Itziar Mincholé, Maider Bizkarguenaga, Enara Arretxe, Marta Iruarrizaga‐Lejarreta, David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo‐Sánchez, Vaclav Smid, Jorge Arnold, Paula Iruzubieta, Ylenia Pérez Castaño, Marcin Krawczyk, Urko M. Marigorta, Martine C.

Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models

Tomasz J. Czernuszewicz, Adam M. Aji, Christopher J. Moore, Stephanie A. Montgomery, Brian Velasco, Gabriela Torres, Keerthi S. Anand, Kennita A. Johnson, Allison M. Deal, Dženan Zukić, Matthew McCormick, Bernd Schnabl, Caterina M. Gallippi, Paul A. Dayton, Ryan C. Gessner – 23 February 2022 – Shear wave elastography (SWE) is an ultrasound‐based stiffness quantification technology that is used for noninvasive liver fibrosis assessment.

LiverLearning®: 2022 Webinar: Going Beyond the Statement: Improving Diversity, Equity and Inclusion in Hepatology

The purpose of this webinar is to discuss action items for the AASLD and academic institutions. These action items will focus on efforts to improve diversity, equity and inclusion in all aspects of the hepatology continuum, including the hepatology work force as well as racial disparities in hepatology care. The webinar will include a formal 10-minute overview of the concepts of diversity, equity and inclusion and another 10-minute formal presentation on proposed future directions outlined in the white paper.

Intratumoral Microbiome of Human Primary Liver Cancer

Dingding Qu, Yi Wang, Qingxin Xia, Jing Chang, Xiangnan Jiang, He Zhang – 21 February 2022 – Primary liver tumors (PLCs) and liver metastasis currently represent the leading cause of cancer‐related deaths worldwide due to poor outcomes, high incidence, and postsurgical recurrence. Hence, novel diagnostic markers and therapeutic strategies for PLCs are urgently needed.

Subscribe to